 |
Previous Article | Next Article 
The Journal of Neuroscience, August 1, 2000, 20(15):5703-5708
Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte
Apoptosis during Primary Demyelination
J. L.
Mason1,
P.
Ye2,
K.
Suzuki3,
A. J.
D'Ercole2, and
G. K.
Matsushima1, 4
1 Curriculum in Neurobiology and University of North
Carolina Neuroscience Center, Departments of
2 Pediatrics, 3 Pathology and Laboratory
Medicine, and 4 Microbiology and Immunology and Program in
Molecular Biology and Biotechnology, University of North Carolina,
Chapel Hill, North Carolina 27599
Metabolic insult results in apoptosis and depletion of mature
oligodendrocytes during demyelination. To examine the role of insulin-like growth factor-1 (IGF-1) during acute demyelination and remyelination in the adult CNS, we exposed transgenic mice that
continuously express IGF-1 (IGF-1 tg) to cuprizone
intoxication. Demyelination was observed within the corpus callosum in
both wild-type and IGF-1 tg mice 3 weeks after exposure
to cuprizone. Wild-type mice showed significant apoptotic mature
oligodendrocytes and a dramatic loss of these cells within the lesion
that resulted in near complete depletion and demyelination by week 5. In contrast, the demyelinated corpus callosum of the IGF-1
tg mice was near full recovery by week 5. This rapid recovery
was apparently caused by survival of the mature oligodendrocyte
population because apoptosis was negligible, and by week 4, the mature
oligodendrocyte population was completely restored. Furthermore,
despite demyelination in both wild-type and IGF-1 tg
mice, oligodendrocyte progenitors accumulated only in the absence of
mature oligodendrocytes and failed to accumulate if the mature
oligodendrocytes remained as demonstrated in the IGF-1
tg mice. These results suggest that IGF-1 may be important in
preventing the depletion of mature oligodendrocytes in
vivo and thus facilitates an early recovery from demyelination.
Key words:
insulin-like growth factor-1; oligodendrocytes; progenitors; myelin; demyelination; apoptosis; mice; transgenic
Copyright © 2000 Society for Neuroscience 0270-6474/00/20155703-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
J. Staiger, M. J. Lueben, D. Berrigan, R. Malik, S. N. Perkins, S. D. Hursting, and P. F. Johnson
C/EBP{beta} regulates body composition, energy balance-related hormones and tumor growth
Carcinogenesis,
May 1, 2009;
30(5):
832 - 840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Irvine and W. F. Blakemore
Remyelination protects axons from demyelination-associated axon degeneration
Brain,
June 1, 2008;
131(6):
1464 - 1477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chandran, D. Hunt, A. Joannides, C. Zhao, A. Compston, and R. J.M Franklin
Myelin repair: the role of stem and precursor cells in multiple sclerosis
Phil Trans R Soc B,
January 12, 2008;
363(1489):
171 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Emery, H. S. Cate, M. Marriott, T. Merson, M. D. Binder, C. Snell, P. Y. Soo, S. Murray, B. Croker, J.-G. Zhang, et al.
Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination
PNAS,
May 16, 2006;
103(20):
7859 - 7864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Settivari, S. Bhusari, T. Evans, P. A. Eichen, L. B. Hearne, E. Antoniou, and D. E. Spiers
Genomic analysis of the impact of fescue toxicosis on hepatic function
J Anim Sci,
May 1, 2006;
84(5):
1279 - 1294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mana, D. Linares, S. Fordham, M. Staykova, and D. Willenborg
Deleterious Role of IFN{gamma} in a Toxic Model of Central Nervous System Demyelination
Am. J. Pathol.,
May 1, 2006;
168(5):
1464 - 1473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther
The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain
Endocr. Rev.,
December 1, 2005;
26(7):
916 - 943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-L. Cui, W.-H. Zheng, R. Quirion, and G. Almazan
Inhibition of Src-like Kinases Reveals Akt-dependent and -independent Pathways in Insulin-like Growth Factor I-mediated Oligodendrocyte Progenitor Survival
J. Biol. Chem.,
March 11, 2005;
280(10):
8918 - 8928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Wilczak, G S. Ramsaransing, J Mostert, D Chesik, and J De Keyser
Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis
Multiple Sclerosis,
February 1, 2005;
11(1):
13 - 15.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Mason, S. Xuan, I. Dragatsis, A. Efstratiadis, and J. E. Goldman
Insulin-Like Growth Factor (IGF) Signaling through Type 1 IGF Receptor Plays an Important Role in Remyelination
J. Neurosci.,
August 20, 2003;
23(20):
7710 - 7718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ye, R. Bagnell, and A. J. D'Ercole
Mouse NG2+ Oligodendrocyte Precursors Express mRNA for Proteolipid Protein But Not Its DM-20 Variant: A Study of Laser Microdissection-Captured NG2+ Cells
J. Neurosci.,
June 1, 2003;
23(11):
4401 - 4405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. John, S. C. Lee, and C. F. Brosnan
Cytokines: Powerful Regulators of Glial Cell Activation
Neuroscientist,
February 1, 2003;
9(1):
10 - 22.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Chaum and H. Yang
Transgenic Expression of IGF-1 Modifies the Proliferative Potential of Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
December 1, 2002;
43(12):
3758 - 3764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ye, L. Li, R. G. Richards, R. P. DiAugustine, and A. J. D'Ercole
Myelination Is Altered in Insulin-Like Growth Factor-I Null Mutant Mice
J. Neurosci.,
July 15, 2002;
22(14):
6041 - 6051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Mason, K. Suzuki, D. D. Chaplin, and G. K. Matsushima
Interleukin-1{beta} Promotes Repair of the CNS
J. Neurosci.,
September 15, 2001;
21(18):
7046 - 7052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. McMahon, D. N. Cook, K. Suzuki, and G. K. Matsushima
Absence of Macrophage-Inflammatory Protein-1{alpha} Delays Central Nervous System Demyelination in the Presence of an Intact Blood-Brain Barrier
J. Immunol.,
September 1, 2001;
167(5):
2964 - 2971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Varlam, M. M. Siddiq, L. A. Parton, and H. Rüssmann
Apoptosis Contributes to Amphotericin B- Induced Nephrotoxicity
Antimicrob. Agents Chemother.,
March 1, 2001;
45(3):
679 - 685.
[Abstract]
[Full Text]
|
 |
|
|

|